Drugs with Pharmacogenomic Tests
Drug
Atomoxetine HCI (Strattera)
Purpose
ADHD treatment
The Gene Factor
Patients with a mutation in the CYP2D6 gene are at risk of suffering serious liver damage.
Drug
Clopidogrel (Plavix)
Purpose
Prevents heart attacks by inhibiting blood clots
The Gene Factor
A variation of the CYP2C19 gene interferes with the way the drug is metabolized, rendering it ineffective.
Drug
Cetuximab (Erbitux) and Panitumumab (Vectibix)
Purpose
Colorectal cancer drug
The Gene Factor
The drugs work only in people whose tumors have a normal KRAS gene.
Drug
Gefitinib (Iressa)
Purpose
Lung cancer drug
The Gene Factor
Works best on people whose tumors have a mutation in the EGFR gene.
Drug
Irinotecan (Camptosar)
Purpose
Colorectal cancer drug
The Gene Factor
People with a genetic variant suffer side effects because they have fewer liver enzymes to break down the drug.
Drug
Tamoxifen (Nolvadex)
Purpose
Breast cancer drug
The Gene Factor
Variations in the CYP2D6 gene can make a person metabolize the drug too quickly or not at all.
Drug
Warfarin (Coumadin)
Purpose
Blood thinner
The Gene Factor
In patients with either or both of two genetic variations, the drug can cause excessive bleeding rather than help prevent blood clots. Genetic testing can reveal the right dose.
Keep Reading
Most Popular
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
How Rust went from a side project to the world’s most-loved programming language
For decades, coders wrote critical systems in C and C++. Now they turn to Rust.
Design thinking was supposed to fix the world. Where did it go wrong?
An approach that promised to democratize design may have done the opposite.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.